Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Psilocybin-Assisted Psychotherapy for the Treatment of Addictive Behaviors
EF 2022-23
Résumé
Substance use disorders and other addictive behaviors such as gambling are globally prevalent and remain a significant public health problem with substantial individual and societal harms. Despite the burden of addictive behaviors, poor treatment outcomes are often reported due to high rates of treatment dropout and relapse. As such, it is necessary to establish more effective treatments for addictive behaviors. Over the past twenty years, a number of studies have examined the effects of the serotonin 2A receptor agonist psilocybin, a naturally occurring psychedelic compound, demonstrating safety and wellbeing benefits when administered to healthy volunteers, and suggesting therapeutic effects across a number of mental disorders. There is also preliminary evidence indicating the safety and potential efficacy of psilocybin-assisted psychotherapy in the treatment of substance use disorders. This postdoctoral research program aims to investigate the effect of psilocybin-assisted psychotherapy for the treatment of tobacco use disorder and cannabis use disorder, while investigating the potential effectiveness of psilocybin-assisted psychotherapy for the treatment of gambling disorder. Through involvement in ongoing and upcoming research studies at Johns Hopkins Medicine, this research program aims to generate evidence specific to the therapeutic efficacy of psilocybin-assisted psychotherapy for the treatment of addictive behaviors. It is hypothesized the psilocybin-assisted psychotherapy will result in significant decreases in tobacco and cannabis use among treatment-seeking adults, while being a potential avenue for clinical research in the treatment of gambling disorder. This research program will have implications at the level of program development and clinical intervention in the treatment of addictive behaviors, with the potential to improve the health and wellbeing of Canadians directly or indirectly impacted by the harms of substance use and addiction.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Maryland, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
471267
Name
Richard Jeremie
Region
Maryland
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Psilocybin-Assisted Psychotherapy for the Treatment of Addictive Behaviors
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Addiction; Conceptual Models; Evidence-Based Treatments; Gambling Disorder; Mental Disorders; Pilot Study; Psilocybin-Assisted Psychotherapy; Psychiatry; Randomized Clinical Trial; Substance Use Disorders
Abstract
Substance use disorders and other addictive behaviors such as gambling are globally prevalent and remain a significant public health problem with substantial individual and societal harms. Despite the burden of addictive behaviors, poor treatment outcomes are often reported due to high rates of treatment dropout and relapse. As such, it is necessary to establish more effective treatments for addictive behaviors. Over the past twenty years, a number of studies have examined the effects of the serotonin 2A receptor agonist psilocybin, a naturally occurring psychedelic compound, demonstrating safety and wellbeing benefits when administered to healthy volunteers, and suggesting therapeutic effects across a number of mental disorders. There is also preliminary evidence indicating the safety and potential efficacy of psilocybin-assisted psychotherapy in the treatment of substance use disorders. This postdoctoral research program aims to investigate the effect of psilocybin-assisted psychotherapy for the treatment of tobacco use disorder and cannabis use disorder, while investigating the potential effectiveness of psilocybin-assisted psychotherapy for the treatment of gambling disorder. Through involvement in ongoing and upcoming research studies at Johns Hopkins Medicine, this research program aims to generate evidence specific to the therapeutic efficacy of psilocybin-assisted psychotherapy for the treatment of addictive behaviors. It is hypothesized the psilocybin-assisted psychotherapy will result in significant decreases in tobacco and cannabis use among treatment-seeking adults, while being a potential avenue for clinical research in the treatment of gambling disorder. This research program will have implications at the level of program development and clinical intervention in the treatment of addictive behaviors, with the potential to improve the health and wellbeing of Canadians directly or indirectly impacted by the harms of substance use and addiction.
Competitiondate
202209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Richard, Jeremie
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~